Document is current
Any future updates will be listed below
-
Authors
Morton, Georgina
Thomas, Sophie
Roberts, Pat
Clark, Vivienne
Imrie, Jackie
Morrison, Alexandra https://orcid.org/0000-0003-3525-5030
-
Funding
Funding for this research was provided by:
Orchard Therapeutics (0001)
- License Information
-
More Information
Article History
Received: 23 June 2022
Revised: 20 September 2022
Accepted: 11 October 2022
First Online: 3 November 2022
Declarations
:
: This study qualifies under the definition of market research and therefore no ethics approval was required. All participants provided informed consent in line with the BHBIA legal and ethical guidelines.
: This was included in the study consent form.
: Rare Disease Research Partners provides professional services to pharmaceutical companies including Orchard Therapeutics.
